Radiotherapy for Solid Tumors
Total Trials
29
As Lead Sponsor
28
As Collaborator
1
Total Enrollment
928
NCT03015883
Alpha Radiation Emitters Device for the Treatment of Squamous Cell Carcinoma
Phase: N/A
Role: Lead Sponsor
Start: Feb 22, 2017
Completion: Jun 25, 2019
NCT03353077
Alpha Radiation Emitters Device for the Treatment of Squamous Cell Carcinoma (DaRT)
Start: Nov 21, 2017
Completion: Jul 14, 2019
NCT03737734
Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia (DaRT)
Start: Dec 31, 2018
Completion: Dec 31, 2025
NCT03970967
Alpha Radiation Emitters Device for the Treatment of Newly Diagnosed Breast Carcinoma Patients With Distant Metastases
Start: Aug 28, 2019
Completion: Nov 30, 2023
NCT04377360
Feasibility Trial of Diffusing Alpha-emitter Radiation Therapy (DaRT) for Malignant Skin & Superficial Soft Tissue Tumors
Start: Jan 6, 2020
Completion: Mar 28, 2022
NCT04002479
Alpha Radiation Emitters Device for the Treatment of Advanced Pancreatic Cancer
Start: Oct 20, 2020
Completion: Oct 31, 2026
NCT03889899
Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia.
Start: Oct 21, 2020
Completion: Sep 30, 2026
NCT04534127
Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia
Start: Dec 22, 2020
Completion: Jan 1, 2026
NCT04540588
Retreatment With Intratumoral Diffusing Alpha Radiation Emitters
NCT03886181
Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal and Superficial Soft Tissue Neoplasia (DaRT)
Start: Jul 8, 2021
Completion: Oct 31, 2025
NCT05047094
A Safety and Efficacy Study for Combinational Treatment of DaRT and Check Point Inhibitor for Recurrent Unresectable or mHNSCC
Start: Nov 2, 2021
Completion: Jun 30, 2027
NCT05125354
A Retrospective Analysis to Evaluate Long Term Outcomes of SCC Patients Previously Treated With Alpha DaRT
Start: Jan 6, 2022
Completion: Mar 6, 2022
NCT04068155
Alpha Radiation Emitters Device for the Treatment of of Malignant Cutaneous Tumors
Start: Apr 1, 2022
Completion: Jan 31, 2025
NCT04543903
Neoadjuvant Interstitial Brachytherapy Using Diffusing Alpha Emitters Radiation Therapy in Men With Prostate Cancer
Start: May 16, 2022
Completion: May 1, 2027
NCT05323253
A Clinical Study to Assess the Efficacy and Safety of Alpha DaRT224 for the Treatment of Patients With Recurrent Cutaneous Squamous Cell Carcinoma
Start: Sep 21, 2022
NCT04761146
A Safety and Efficacy Study of Intra-tumoural Diffusing Alpha Radiation Emitters for the Treatment of Vulva Cancer
Role: Collaborator
Start: Feb 28, 2023
NCT05781555
A Study of Diffusing Alpha Radiation Therapy for Target Treatments of Malignant Tumors
Start: Mar 22, 2023
Completion: Apr 30, 2025
NCT05632913
Alpha Radiation Emitters Device for the Treatment of Recurrent Lung Cancer
Start: Jul 1, 2023
Completion: Feb 28, 2027
NCT05657743
A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Advanced Pancreatic Cancer
Start: Aug 16, 2023
Completion: Nov 30, 2025
NCT05829291
Alpha Radiation Emitters Device for the Treatment of Liver Metastases (DaRT)
Start: Oct 1, 2023
Completion: Feb 28, 2026
NCT06202118
A Study of Diffusing Alpha Radiation Therapy for Patients With Breast Carcinoma in Frail or Elderly Patients.
Start: Feb 19, 2024
Completion: Jun 30, 2026
NCT06202248
A Study to Assess Alpha DaRT224 for the Treatment of Men With Non-metastatic Locally Recurrent Prostate Cancer
Start: Mar 12, 2024
NCT06202339
Alpha Radiation Emitters Device for the Treatment of Primary and Recurrent Squamous Cell Carcinoma of the Vulva (DaRT).
Start: Apr 30, 2024
Completion: Dec 31, 2026
NCT06026943
Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer Emitters for the Treatment of Locally Advanced Pancreatic Cancer
Start: Jan 31, 2025
Completion: Jan 31, 2028
NCT05065346
Neoadjuvant DaRT for Locally Advanced Oral Cavity SCC
Start: Mar 31, 2025
NCT06755359
Alpha Radiation Emitters Device (DaRT) for the Treatment of Locally Advanced Pancreatic Cancer
Start: Apr 30, 2025
NCT06698458
Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer
Start: Jun 17, 2025
NCT06910306
A Study to Assess the Feasibility and Safety of Intratumoral Diffusing Alpha Emitters for the Treatment of Recurrent Glioblastoma
Start: Sep 1, 2025
Completion: Dec 1, 2026
NCT06615635
Clinical Study Protocol for Cutaneous SCC for Immunocompromised Patients
Start: Dec 31, 2025
Loading map...